_____________________________________________________________________

Free Case Evaluation: YAZ / Yasmin / Beyaz / Safyral / Ocella / Gianvi 

The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.

______________________________________________________________

My Articles About Yaz / Yasmin / Beyaz / Safyral / Ocella / Gianvi

December 2014 YAZ / Yasmin Litigation Update: Still Over 2000 DVT And/Or PE Cases Not Settled According To Bayer’s Most Recent Financial Report
 
And New Blood Clot Side Effect Lawsuits, Including Some Involving The Lesser-Known Safyral And Beyaz DRSP Pills, Are Still Being Filed Against Bayer

SUMMARY: From Bayer’s Stockholders’ Newsletter Financial Report as of September 30, 2014, published on October 30, 2014:

As of October 13, 2014, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 9,200 claimants in the U.S. for a total amount of about US$1.8 billion. Bayer has only been settling claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) after a case-specific analysis of medical records on a rolling basis. Such injuries are alleged by about 2,100 of the pending unsettled claimants. Bayer will continue to consider the option of settling such individual lawsuits in the U.S. on a case-by-case basis.

To put all of this into context, the YAZ / Yasmin litigation began back in mid-2009 when the first lawsuits against Bayer were filed.  In January 2012 Bayer decided to begin to attempt to negotiate settlements for YAZ / Yasmin / Ocella / Gianvi blood clot lawsuits, e.g., deep vein thrombosis (DVT) or pulmonary embolism (PE), on a case-by-case basis.  And new lawsuits, including some cases involving Safyral and Beyaz, are still being filed against Bayer to date.

[Read this article in full at original source]

 
Earlier DRSP Birth Control Pills articles by Tom Lamb on the Drug Injury Watch blog:

Drug Injury Watch: Summer 2014 Update YAZ / Yasmin / Ocella / Gianvi Litigation: Bayer Reports On Total Settlements And Number Of Pending Claims

Drug Injury Watch: About 2000 YAZ / Yasmin / Ocella / Gianvi Blood Clot Cases Are Still Not Settled More Than Two Years After Bayer Began Settlement Mediations

Drug Injury Watch: During 2013 Bayer Has Had More Than 2000 YAZ / Yasmin Lawsuits For Blood Clots That Are Not Settled

Drug Injury Watch: YAZ / Yasmin Products Liability Litigation: February 2014 Bayer Information About The Number Of Claims, Lawsuits, And Settlements

Drug Injury Watch: During 2013 Bayer Has Had More Than 2000 YAZ / Yasmin Lawsuits For Blood Clots That Are Not Settled

Drug Injury Watch: YAZ / Yasmin / Ocella / Gianvi Blood Clot Lawsuits That Are Not Settled Yet: Number Increases, Indicating That These Legal Claims Continue To Be Filed In 2013

Drug Injury Watch: Legal Claims May Be Possible In California For Gianvi, Zarah, Loryna, Syeda, And Vestura (Generic YAZ / Yasmin) Blood Clot Side Effects Due To Pikerie v. Teva Case Ruling

Drug Injury Watch: Summer 2013 Bayer Lawsuits Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits Continue To Be Settled, With New Cases Being Filed

Drug Injury Watch: As Bayer Settlements For YAZ, Yasmin, Ocella, And Gianvi Continue In 2013, Total Payments Will Go Over The $1 Billion Level

Drug Injury Watch: Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe

Drug Injury Watch: November 2012 Litigation And Settlement Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits

Drug Injury Watch: 2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots

Drug Injury Watch: Bayer Settlements: Gianvi / Ocella / Yasmin / YAZ: July 2012 Update On Drug Injury Lawsuits Filed To Date

Drug Injury Watch: Medical Study Finds Link Between YAZ / Yasmin And Irritable Bowel Syndrome (IBS) Coming From Drospirenone (DRSP) Progestin

Drug Injury Watch: Bayer Settlements For YAZ / Yasmin Lawsuits Involving Blood Clot Side Effects Like Deep Vein Thrombosis And Pulmonary Embolism

Drug Injury Watch: April 2012 Yasmin / YAZ Label Change: FDA Warns About Increased Risk Of Blood Clots Possible Due To Drospirenone

Drug Injury Watch: YAZ / Yasmin Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012

Drug Injury Watch: Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills

Drug Injury Watch: Gianvi Legal Claims Against Drug Company Still Possible Despite Mensing Case Rule Against Generic Drug Injury Lawsuits

Drug Injury Watch: YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More)

Drug Injury Watch: YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online

Drug Injury Watch: Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting

________________________________________________________

 

Free Case Evaluation: YAZ / Yasmin / Beyaz / Safyral / Ocella / Gianvi

The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.